Oct. 13, 2010 -- The bisphosphonate class of osteoporosis drugs -- including Actonel, Atelvia, Boniva, Fosamax, Reclast, and generics -- may raise the risk of thigh bone fracture, the FDA warns.
There's no proof that the drugs cause the rare, serious thigh fractures called atypical femur fractures. But these events are more common in patients taking bisphosphonates than in patients taking other osteoporosis drugs.
For that reason, the FDA today issued a warning to patients. That warning will appear on the drugs' labels.
via webmd.com
No comments:
Post a Comment